| P2093 | author name string | Rong Jin | |
| | Guohong Li | |
| | Min Wang | |
| | Jarvis Li | |
| | Adam Y Xiao | |
| P2860 | cites work | Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia. | Q47919801 |
| | Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke | Q48092753 |
| | Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination | Q48347152 |
| | Involvement of phosphoinositide 3-kinase gamma in the neuro-inflammatory response and cognitive impairments induced by beta-amyloid 1-40 peptide in mice | Q48373086 |
| | Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage | Q48384211 |
| | Resolving Thromboinflammation in the Brain After Ischemic Stroke? | Q48761468 |
| | Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. | Q50308473 |
| | Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. | Q52587502 |
| | The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice. | Q54684259 |
| | Thrombectomy for Acute Ischemic Stroke: Recent Insights and Future Directions | Q57175027 |
| | Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat | Q57179001 |
| | Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke | Q58713675 |
| | Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion | Q72157165 |
| | Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats | Q73563868 |
| | Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke | Q73718399 |
| | Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke | Q73746642 |
| | Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion | Q80553678 |
| | Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset | Q26796477 |
| | Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke | Q29619330 |
| | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Q30238784 |
| | Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats | Q30826562 |
| | Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials | Q31048053 |
| | MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. | Q33322709 |
| | Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. | Q33684529 |
| | Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years | Q33966207 |
| | Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke | Q35086740 |
| | Phosphoinositide 3-kinase-gamma expression is upregulated in brain microglia and contributes to ischemia-induced microglial activation in acute experimental stroke | Q35202539 |
| | Platelet–leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke | Q35633718 |
| | Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions | Q35656802 |
| | Phosphoinositide 3-Kinase Gamma Contributes to Neuroinflammation in a Rat Model of Surgical Brain Injury | Q35876779 |
| | Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke | Q35905986 |
| | The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes | Q35976619 |
| | Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats | Q36788142 |
| | Hypertension and experimental stroke therapies | Q37073438 |
| | NF‐κB and innate immunity in ischemic stroke | Q37252167 |
| | Microvascular protection is essential for successful neuroprotection in stroke. | Q38050820 |
| | Animal models of ischemic stroke and their application in clinical research | Q38546471 |
| | Thromboinflammation in Stroke Brain Damage | Q38703081 |
| | Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats | Q39791602 |
| | Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke. | Q40458860 |
| | Seizures and recovery from experimental brain damage | Q41405943 |
| | Extension of the thrombolytic time window with minocycline in experimental stroke. | Q41812595 |
| | Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion | Q42509508 |
| | Resistance to thromboembolism in PI3Kgamma-deficient mice. | Q43711871 |
| | Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia | Q43820256 |
| | Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats | Q43901758 |
| | PI3K-γ inhibition ameliorates acute lung injury through regulation of IκBα/NF-κB pathway and innate immune responses | Q44300358 |
| | Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons | Q45007330 |
| | PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus | Q46674138 |
| | Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. | Q46674143 |
| | Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes | Q46758917 |
| | Platelet CD40 Mediates Leukocyte Recruitment and Neointima Formation after Arterial Denudation Injury in Atherosclerosis-Prone Mice | Q47645034 |
| P433 | issue | 1 | |
| P921 | main subject | plasminogen | Q107129060 |
| | embolic stroke | Q107538662 |
| P304 | page(s) | 206-216 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke | |
| P478 | volume | 73 | |